export const hormonesData = {
  name: "Hormones",
  subtopics: {
    essay: {
      name: "Essay",
      questions: [
        "Anti-Diabetic Drugs ******** (Sep 21;Feb 18;Aug 13;Aug 09;Feb 07;Feb 05;Oct 96;Jan 93) (Pg.No: 285;Pg.No: 293;Pg.No: 294;Pg.No: 299;TV5-Pg.No: 358;TV5-Pg.No: 361;TV5-Pg.No: 362)\n– Classification of Oral Hypoglycaemic Drugs, Mechanism of Action, Adverse Effects, Interaction of Sulfonyl Ureas\n– Classification of Oral Hypoglycemic Drugs, Mechanism of Action and Adverse Effects of Metformin, Reason for Metformin being used as First Choice Drug in Type 2 DM patients\n– Newer Insulin Analogues, Insulin Resistance\nProbable Cases:\n– A 48 year old obese male with sedentary lifestyle, presents with symptoms and blood sugar levels suggestive of diabetes mellitus, FBS 120 mg/dL, post prandial blood sugar 260 mg/dL",
        "Anti-Thyroid Drugs ****** (Nov 20;Feb 13;Aug 10;Feb 06;Nov 01;Apr 00;Oct 99) (Pg.No: 274;TV5-Pg.No: 324)\n– Classification of Antithyroid Drugs, Mechanism of Action, Adverse Effects, Advantages, Contraindications, Management of Thyroid Storm\n– Radioactive Iodine\nProbable Cases:\n– A 35 year old female presented with Fatigue, weakness, decreased appetite, puffy face and menorrhagia. Routine investigations, lipid profile and thyroid function tests were done\n– High TSH and low levels of T3 and T4 was found",
        "Corticosteroids *** (Aug 06;Aug 05;Apr 01) (Pg.No: 306;TV5-Pg.No: 346)\n– Classification of Glucocorticoids, Physiological and Pharmacological Actions, Adverse Effects, Therapeutic Uses, Contraindications\n– Note on Acute Adrenal Insufficiency",
        "Oral Contraceptives *** (Aug 11;Mar 02;Oct 00) (Pg.No: 346;TV5-Pg.No: 339)\n– Classification of Anti Fertility Drugs, Methods of Administration, Mechanism of Action, Adverse Effects\n– Adverse Effects and Complications of Hormonal Contraceptives"
      ]
    },
    "short-note": {
      name: "Short Note",
      questions: [
        "Oral Contraceptive Pills ******** (Aug 17;Aug 12;Feb 11;Aug 09;Feb 09;Feb 07;Aug 05;Dec 91) (Pg.No: 346;TV5-Pg.No: 339)",
        "Glucocorticoids ****** (Feb 23;Feb 11;Aug 09;Feb 07;Aug 04;Nov 95) (Pg.No: 306;TV5-Pg.No: 353)\n- Uses, Adverse Effects",
        "Newer Insulins ***** (Aug 18;Aug 10;Aug 05;Oct 98;Apr 97) (Pg.No: 287;TV5- Pg.No: 358)",
        "Radioactive Iodine **** (Feb 23;Feb 19;Aug 14;Apr 92) (Pg.No: 277;TV5- Pg.No: 326)",
        "Selective Estrogen Receptor Modulators (SERMs) **** (Mar 22;Aug 18;Aug 10;Feb 06) (Pg.No: 337;TV5-Pg.No: 335)",
        "Tocolytics **** (Jul 23;Aug 22;Aug 08;Feb 06) (Pg.No: 358;TV5-Pg.No: 378)",
        "Propylthiouracil *** (Feb 18;Aug 11;Aug 04) (Pg.No: 275;TV5-Pg.No: 325)",
        "Anabolic Steroids ** (Feb 09;Apr 99) (Pg.No: 325;TV5-Pg.No: 329)\n- Uses, Adverse Effects",
        "Anti-Thyroid Drugs ** (Aug 09;Feb 08) (Pg.No: 274;TV5-Pg.No: 324)",
        "Carbimazole ** (Feb 10;Dec 90) (Pg.No: 275;TV5-Pg.No: 325)",
        "Hormone Replacement Therapy (HRT) ** (Feb 10;Feb 06) (Pg.No: 334;TV5- Pg.No: 332)",
        "Injectable Contraceptives ** (Nov 20;Aug 06) (Pg.No: 348;TV5-Pg.No: 342)",
        "Insulin Resistance ** (Aug 11;Feb 11) (Pg.No: 292;TV5-Pg.No: 361)",
        "Sulfonyl Ureas ** (Feb 09;Oct 97) (Pg.No: 294;TV5-Pg.No: 362)\n- Mechanism, Pharmacological Actions",
        "Adverse Effects of Hormonal Contraceptives (Aug 04) (Pg.No: 350;TV5- Pg.No: 343)",
        "Bisphosphonates (Aug 04) (Pg.No: 369;TV5-Pg.No: 374)",
        "Clinical Uses of Somatostatin and Octreotide (Aug 15) (Pg.No: 259;TV5- Pg.No: 316)",
        "Combined Pill (Feb 10) (Pg.No: 346;TV5-Pg.No: 339)",
        "Management of Diabetic Ketoacidosis (Aug 10) (Pg.No: 291;TV5-Pg.No: 361)",
        "Ovulation Inducing Agents (Feb 09) (Pg.No: 262;TV5-Pg.No: 317)",
        "Uterine Stimulants (Feb 05) (Pg.No: 354;TV5-Pg.No: 375)"
      ]
    }
  }
};